X4 Pharmaceuticals Q4 EPS $(1.24) Down From $(0.91) YoY
X4 Pharmaceuticals (NASDAQ:XFOR) reported quarterly losses of $(1.24) per share. This is a 36.26 percent decrease over losses of $(0.91) per share from the same period last year.
X4 Pharmaceuticals (NASDAQ:XFOR) reported quarterly losses of $(1.24) per share. This is a 36.26 percent decrease over losses of $(0.91) per share from the same period last year.